⌘K

Login Start Free

Home/Filings/4/0001628280-21-012469

4//SEC Filing

Balakrishnan Brinda 4

Accession 0001628280-21-012469

CIK 0001600620other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:39 PM ET

Size

5.2 KB

Accession

0001628280-21-012469

Insider Transaction Report

Form 4

Period: 2021-06-14

Aurinia Pharmaceuticals Inc.AUPH

Balakrishnan Brinda

Director

Transactions

Award
Stock Option (right to buy)
2021-06-14+53,291→ 53,291 total
Exercise: $12.86Exp: 2031-06-14→ Common Shares (53,291 underlying)

Footnotes (1)

[F1]The option vests in twelve equal monthly installments commencing on July 14, 2021.

Documents

1 file

4
wf-form4_162396231828957.xmlPrimary
FORM 4

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1

filerCIK 0001868236

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 4:39 PM ET
Size: 5.2 KB

View on SEC.gov